Rocket


News + Filings
Transactions





Webster Stephen W

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/08/2023Cullinan Oncology, Inc. GrantStock Option (Right to Buy)18.4k$13.00$239.8k 06/08/2023
06/01/2023TCR2 THERAPEUTICS INC.TCRRDispositionStock Option (Right to Buy)16.8k$0.97$16.3k 06/01/2023
06/01/2023TCR2 THERAPEUTICS INC.TCRRDispositionStock Option (Right to Buy)12.1k$31.83$385.1k 06/01/2023
06/01/2023TCR2 THERAPEUTICS INC.TCRRDispositionStock Option (Right to Buy)12.1k$5.21$63k 06/01/2023
06/01/2023TCR2 THERAPEUTICS INC.TCRRDispositionStock Option (Right to Buy)10.5k$9.54$100k 06/01/2023
12/15/2022TCR2 THERAPEUTICS INC.TCRRGrantStock Option (Right to Buy)16.8k$0.97$16.3k 12/15/2022
08/02/2022Nabriva Therapeutics plcNBRVSaleOrdinary Shares7.8k$0.19$1.5k 08/02/2022
06/23/2022NextCure, Inc.NXTCGrantStock Option (Right to Buy)14.2k$4.77$68k 06/23/2022
06/22/2022Cullinan Oncology, Inc. GrantStock Option (Right to Buy)16.5k$12.73$209.7k 06/22/2022
12/09/2021TCR2 THERAPEUTICS INC.TCRRGrantStock Option (Right to Buy)12.1k$5.21$63k 12/09/2021
09/16/2021Cullinan Oncology, Inc. GrantStock Option (Right to Buy)7.8k$28.80$224.6k 09/16/2021
08/02/2021Nabriva Therapeutics plcNBRVSaleOrdinary Shares777$1.20$932.4 08/02/2021
07/28/2021Nabriva Therapeutics plcNBRVGrantShare Options35k$1.08$37.8k 07/28/2021
07/28/2021Nabriva Therapeutics plcNBRVGrantOrdinary Shares17.5k$0.00$0 07/28/2021
06/24/2021NextCure, Inc.NXTCGrantStock Option (Right to Buy)14.2k$8.21$117k 06/24/2021
12/10/2020TCR2 THERAPEUTICS INC.TCRRGrantStock Option (Right to Buy)12.1k$31.83$385.1k 12/10/2020
07/29/2020Nabriva Therapeutics plcNBRVGrantOrdinary Shares17.5k$0.00$0 07/29/2020
07/29/2020Nabriva Therapeutics plcNBRVGrantStock Options35k$0.79$27.6k 07/29/2020
06/11/2020NextCure, Inc.NXTCGrantStock Option (Right to Buy)14.2k$24.13$343.9k 06/11/2020
04/30/2020TCR2 THERAPEUTICS INC.TCRRGrantStock Option (Right to Buy)10.5k$9.54$100k 04/30/2020
01/02/2020Viking Therapeutics, Inc.VKTXGrantStock Option (Right to Buy)22k$7.95$174.9k 01/02/2020
12/17/2019Spark Therapeutics, Inc.ONCEOtherCommon Stock6.1k$114.50$698.7k 12/17/2019
12/17/2019Spark Therapeutics, Inc.ONCEDispositionStock Option (Right to Buy)35k$42.73$1.5M 12/17/2019
12/17/2019Spark Therapeutics, Inc.ONCEDispositionStock Option (Right to Buy)28k$50.55$1.4M 12/17/2019
12/17/2019Spark Therapeutics, Inc.ONCEDispositionStock Option (Right to Buy)25k$56.17$1.4M 12/17/2019
12/17/2019Spark Therapeutics, Inc.ONCEDispositionStock Option (Right to Buy)55k$40.44$2.2M 12/17/2019
12/17/2019Spark Therapeutics, Inc.ONCEDispositionStock Option (Right to Buy)60k$68.45$4.1M 12/17/2019
12/17/2019Spark Therapeutics, Inc.ONCEDispositionStock Option (Right to Buy)106k$3.45$365.8k 12/17/2019
12/17/2019Spark Therapeutics, Inc.ONCEDispositionRestricted Stock Units19.5k$0.00$0 12/17/2019
07/31/2019Nabriva Therapeutics plcNBRVGrantStock Option35k$0.00$0 07/31/2019
06/13/2019NextCure, Inc.NXTCGrantStock Option (Right to Buy)22k$15.57$342.5k 06/13/2019
01/18/2019Spark Therapeutics, Inc.ONCEExerciseRestricted Stock Units2k$0.00$0 01/18/2019
01/18/2019Spark Therapeutics, Inc.ONCEExerciseRestricted Stock Units1.8k$0.00$0 01/18/2019
01/18/2019Spark Therapeutics, Inc.ONCEPayment of ExerciseCommon Stock634$45.08$28.6k 01/18/2019
01/18/2019Spark Therapeutics, Inc.ONCEPayment of ExerciseCommon Stock629$45.08$28.4k 01/18/2019
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy